Resalis Therapeutics Revenue and Competitors

Turin, it

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Resalis Therapeutics has 10 Employees.(i)
  • Resalis Therapeutics grew their employee count by 11% last year.

Resalis Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A1011%N/AN/A
#2
N/A60%N/AN/A
Add Company

What Is Resalis Therapeutics?

Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. \n \nThe company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis.\n\nBuilding on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.

keywords:N/A

N/A

Total Funding

10

Number of Employees

N/A

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M11N/AN/A
#2
$1.1M138%N/A
#3
N/A2686%N/A
#4
$11.8M50-9%N/A
#5
$6.6M68-1%N/A